Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.

The Journal of clinical endocrinology and metabolism - 1 Jul 2003

Van Pottelbergh I, Goemaere S, Kaufman J M

Abstract excerpt

The question of whether and to what extent the sex steroid deficiency in elderly men contributes to the pathogenesis of bone loss has not been fully explored. The aim of the present study was to assess the association of serum bioavailable (Bio) estradiol (E(2)) with the evolution of bone mineral density (BMD) in 214 community-dwelling men aged 71-86 yr as well as the possible modulation of estrogen effects by a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged, 80 and over
Share to Aromatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Bone and Bones

Share to Bone Density

Share to Estradiol

Share to Gonadal Steroid Hormones

Share to Longitudinal Studies

Share to Osteoporosis

Source

Identifiers

PMID: 12843146
DOI: 10.1210/jc.2002-021691

Genes

SHBG

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Bioavailable estradiol and an aromatase gene polymorphism are determinants of bone mineral density changes in men over 70 years of age.PMID 12843146Read ↗

Relation of aromatase gene polymorphism and hormone replacement therapy to serum estradiol levels, bone mineral density, and fracture risk in early postmenopausal women.Semantic proximity Read ↗

Association of an aromatase TTTA repeat polymorphism with circulating estrogen, bone structure, and biochemistry in older women.Semantic proximity Read ↗

A polymorphic CYP19 TTTA repeat influences aromatase activity and estrogen levels in elderly men: effects on bone metabolism.Semantic proximity Read ↗

A common polymorphism in the 5'-untranslated region of the aromatase gene influences bone mass and fracture risk.Semantic proximity Read ↗

Perturbed sex steroid status in men with idiopathic osteoporosis and their sons.Semantic proximity Read ↗

Polymorphisms in the CYP19 and AR genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy: The Danish Osteoporosis Prevention Study.Semantic proximity Read ↗

Association of the (TTTA)n repeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women.Semantic proximity Read ↗

Genetic polymorphism at Val80 (rs700518) of the CYP19A1 gene is associated with aromatase inhibitor associated bone loss in women with ER + breast cancer.Semantic proximity Read ↗

Aerobic exercise and bone mineral density in middle-aged finnish men: a controlled randomized trial with reference to androgen receptor, aromatase, and estrogen receptor alpha gene polymorphisms.Semantic proximity Read ↗

Age-related influence of common aromatase gene polymorphisms on bone mass of healthy men.Semantic proximity Read ↗

Genetic variations in sex steroid-related genes as predictors of serum estrogen levels in men.Semantic proximity Read ↗

Polymorphisms in the CYP19 gene that influence bone mineral density.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.